Cullinan Therapeutics, Inc. (CGEM) vs Corvus Pharmaceuticals, Inc. (CRVS)

Cullinan Therapeutics, Inc. and Corvus Pharmaceuticals, Inc. are both Biotechnology companies. Cullinan Therapeutics, Inc. and Corvus Pharmaceuticals, Inc. are of similar size ($992.6M and $992.4M). Across the 9 metrics below, Corvus Pharmaceuticals, Inc. leads on 7 and Cullinan Therapeutics, Inc. on 2.

Valuation

Metric CGEM CRVS Biotechnology median
P/E n/m n/m 7.88
P/S n/m n/m 11.47
P/B 2.82 4.76 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales n/m n/m 10.73
Earnings yield (21.05%) (5.25%) (28.84%)
Free cash flow yield (17.59%) (4.21%) (23.03%)

Profitability

Metric CGEM CRVS Biotechnology median
Gross margin — 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (50.30%) (18.98%) (57.72%)
Return on assets (46.30%) (17.64%) (49.22%)
Return on invested capital 0.00% (352.49%) 0.00%

Growth

Metric CGEM CRVS Biotechnology median
Revenue growth (TTM) — — 5.64%
EPS growth (last fiscal year) (20.86%) 81.21% —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CGEM CRVS Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 8.42 16.16 4.73
Net debt to EBITDA 1.57 1.28 0.96

Dividend

Metric CGEM CRVS Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric CGEM CRVS Biotechnology median
Market cap 992.35m 992.63m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack